Frontlight ResearchEarly access
Trial site
Retina Consultants of Texas: San Antonio
- 8running trials
- 4closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Macular degeneration5 trials
- Diabetic eye disease4 trials
- Retinitis pigmentosa1 trial
- Phase
- Phase 35 trials
- Phase 1/23 trials
- Phase 23 trials
- Phase 41 trial
- Status
- Active, not recruiting6 trials
- Completed4 trials
- Recruiting2 trials
- Lead sponsor
- Kodiak Sciences Inc3 trials
- 4D Molecular Therapeutics1 trial
- Alcon Research1 trial
- Annexon, Inc.1 trial
- Avirmax Biopharma Inc1 trial
- and 5 more
Running trials
Active, not recruiting
High Dose Eylea for Proliferative Diabetic Retinopathy Outcomes
Recruiting
Recruiting
Active, not recruiting
Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)
Active, not recruiting
4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Active, not recruiting
Active, not recruiting
Active, not recruiting
Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD)
Closed trials
Completed
Completed
Completed
Oxulumis® Suprachoroidal Microcatherization of Triesence® in Diabetic Macular Edema
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026